NO950602L - Antiangiogeniske oligomerer - Google Patents

Antiangiogeniske oligomerer

Info

Publication number
NO950602L
NO950602L NO950602A NO950602A NO950602L NO 950602 L NO950602 L NO 950602L NO 950602 A NO950602 A NO 950602A NO 950602 A NO950602 A NO 950602A NO 950602 L NO950602 L NO 950602L
Authority
NO
Norway
Prior art keywords
oligomers
antiangiogenic
polyureas
metastases
polycarbonates
Prior art date
Application number
NO950602A
Other languages
English (en)
Other versions
NO950602D0 (no
Inventor
Paul Steven Wright
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO950602L publication Critical patent/NO950602L/no
Publication of NO950602D0 publication Critical patent/NO950602D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Oligomerene ifølge oppfinnelsen er polyureaer, polykarbonater, poly- estere eller polyamider med en antalls- midlere molekylvekt på < 10 000. Disse oligomerer er vannløselige, har en stiv ryggrad med en forutsigbar anionavstand og er farmasøytisk akseptable. Oligo- merene er anvendbare for inhibering av angiogenese og kan anvendes ved behand- ling av tumorer og metastaser.
NO950602A 1992-08-19 1995-02-17 Antiangiogeniske oligomerer NO950602D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93211192A 1992-08-19 1992-08-19
PCT/US1993/006792 WO1994004165A1 (en) 1992-08-19 1993-07-20 Antiangiogenic oligomers

Publications (2)

Publication Number Publication Date
NO950602L true NO950602L (no) 1995-02-17
NO950602D0 NO950602D0 (no) 1995-02-17

Family

ID=25461789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950602A NO950602D0 (no) 1992-08-19 1995-02-17 Antiangiogeniske oligomerer

Country Status (12)

Country Link
US (1) US5593664A (no)
EP (1) EP0655923A1 (no)
JP (1) JPH08500590A (no)
AU (1) AU675961B2 (no)
CA (1) CA2142110A1 (no)
HU (1) HUT72993A (no)
IL (1) IL106707A (no)
MX (1) MX9305010A (no)
NO (1) NO950602D0 (no)
NZ (1) NZ254646A (no)
WO (1) WO1994004165A1 (no)
ZA (1) ZA935941B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0749690A1 (en) 1995-06-22 1996-12-27 Unilever N.V. Heat-settable, frozen bakery dough systems
AUPO104496A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US20040022788A1 (en) * 1998-05-19 2004-02-05 Moser Tammy L. Compositions and methods for promoting or inhibiting angiogenesis
PT1520588E (pt) 1998-07-13 2015-03-31 Univ Texas Usos de anticorpos para amino fosfolípidos para o tratamento do cancro
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
GB0001481D0 (en) * 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
NZ537690A (en) 2002-07-15 2009-07-31 Univ Texas Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
WO2005025515A2 (en) * 2003-09-12 2005-03-24 California Institute Of Technology Proteasome pathway inhibitors and related methods
ME01881B (me) 2004-01-22 2014-12-20 Univ Miami Topijske formulacije koenzima q10 i postupci upotrebe
KR101502267B1 (ko) 2007-11-09 2015-03-18 페레그린 파마수티컬즈, 인크 항-ｖｅｇｆ 항체 조성물 및 방법
CA2737146A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
CN102382300B (zh) * 2011-10-11 2013-05-08 上海交通大学 一种水溶性磺化聚酰胺及其制备方法
US10786471B2 (en) 2017-02-06 2020-09-29 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
WO1980000151A1 (en) * 1978-07-03 1980-02-07 American Home Prod N-(3-alkylaminopropyl)-n'-phenylureas
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US5019556A (en) * 1987-04-14 1991-05-28 President And Fellows Of Harvard College Inhibitors of angiogenin
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process

Also Published As

Publication number Publication date
IL106707A (en) 1997-02-18
CA2142110A1 (en) 1994-03-03
ZA935941B (en) 1994-03-10
IL106707A0 (en) 1993-12-08
NZ254646A (en) 1997-06-24
HUT72993A (en) 1996-06-28
JPH08500590A (ja) 1996-01-23
US5593664A (en) 1997-01-14
WO1994004165A1 (en) 1994-03-03
HU9500493D0 (en) 1995-04-28
NO950602D0 (no) 1995-02-17
EP0655923A1 (en) 1995-06-07
AU675961B2 (en) 1997-02-27
AU4684893A (en) 1994-03-15
MX9305010A (es) 1994-03-31

Similar Documents

Publication Publication Date Title
NO950602L (no) Antiangiogeniske oligomerer
CA2086438A1 (en) Anti-herpes virus and cytomegalovirus oligomers
ZA945005B (en) Heparin derivatives having antimetastatic activity
WO1997045137A8 (en) Methods and compositions useful for inhibition of angiogenesis
EP1298211A3 (en) Polynucleotide segment of HPV16 Genome
TW225514B (no)
EP0682665A4 (en) ANTHRAQUINONE AND ANTHRACENE DERIVATIVES INHIBITING CELL ADHESION MOLECULES OF THE IMMUNE SYSTEM.
HUP0101073A2 (hu) Közepes sűrűségű etilén polimerek, eljárás előállításukra és karbonilcsoportot tartalmazó láncátvivő szerek alkalmazása az eljárásnál
IT8720349A0 (it) Struttura di girante girevole, in particolare per l&#39;impiego in apparecchiature soffianti.
EP0328495A3 (en) System for the safe and secure transportation of valuable articles, such as bank notes, cheques etc.
DE69033132D1 (de) Mesogene Polycyanate und Polycyanamide und ihre hitzegehärteten Gegenstände
EP0613907A3 (en) Controlled reduction of the polymer molecular weight.
Steblyk The nature lyric in Japanese Canadian" Nisei" poetry of identity
ITGE940033V0 (it) Girarrosto per carni del tipo cosidetto &#34;gyros&#34;.
韩孝族 et al. SYNTHESIS AND CHARACTERIZATION OF BLOCK POLYMER OF ALTERNATING COPOLYMERS
Casta et al. Progress in the Understanding and Prevention of Corrosion. Vol. II
IT9047812A0 (it) Complesso per la stabilizzazione del rachide dorso-lombo-sacrale e relativo metodo di stabilizzazione.
Augustin et al. PRETREATMENT OF STEEL SURFACES FOR CORROSION PROTECTION
Pasloske Molecular studies of the NMePhe Pilin of Pseudomonas aeruginosa
Wennerholm Solfångares kvalitet och beständighet i Sverige. Del 2 Konvektionshinder av FEP-film-Skadeutredning.
IT8904854A0 (it) Sistema di protezione del terreno contro l&#39;erosione.
Hobden The contract security guard industry in Alberta
IT8814715V0 (it) Separatore di oggetti estranei, tipo siringhe e fiammiferi dalla corrispondenza inserita nelle cassette di impostazione mod.x-bb-883/v
IT8919122A0 (it) Impianto di sicurezza per la detenzione e la movimentazione di valori e documenti.
ITTO971044A1 (it) Procedimento per l&#39;accrescimento del peso molecolare di resine poliestere.